Geneviève Plu-Bureau Selected Research

Geneviève Plu-Bureau Research Topics

Disease

22	Venous Thromboembolism 09/2020 - 08/2003
9	Venous Thrombosis (Deep-Vein Thrombosis) 09/2020 - 12/2004
7	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2004
5	Thrombophilia 01/2019 - 10/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 07/2006
4	Stroke (Strokes) 01/2016 - 07/2006
3	Endometriosis 01/2022 - 01/2008
3	Hypertension (High Blood Pressure) 01/2021 - 11/2012
3	Thrombosis (Thrombus) 10/2017 - 06/2012
2	Migraine Disorders (Migraine) 11/2019 - 01/2008
2	Neoplasms (Cancer) 09/2019 - 05/2004
2	Activated Protein C Resistance (APC Resistance) 02/2017 - 11/2010
2	Ischemic Stroke 01/2016 - 02/2013
2	Myocardial Infarction 02/2013 - 04/2011
2	Obesity 11/2012 - 01/2008
1	Dysmenorrhea (Menstrual Pain) 01/2022
1	Amenorrhea 12/2021
1	Meningioma (Meningiomas) 04/2021
1	Angioedema 01/2021
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Hereditary Angioedemas 01/2021
1	Osteoporosis 11/2019
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2019
1	Thromboembolism 09/2019
1	Habitual Abortion (Recurrent Miscarriage) 01/2019
1	Pulmonary Embolism 08/2017
1	Hemorrhagic Stroke 02/2013
1	Dyslipidemias (Dyslipidemia) 11/2012
1	Endometrial Neoplasms (Endometrial Cancer) 12/2011
1	Hot Flashes 10/2010
1	Lung Neoplasms (Lung Cancer) 01/2010
1	Renal Insufficiency (Renal Failure) 01/2008
1	Fibroma (Fibromatosis) 01/2008
1	Epilepsy (Aura) 01/2008
1	Breast Diseases (Breast Disease) 01/2008
1	Uterine Diseases (Endometrial Disease) 01/2008
1	Vascular Diseases (Vascular Disease) 01/2008
1	Brain Neoplasms (Brain Tumor) 01/2008
1	Adenoma (Adenomas) 01/2008
1	Metabolic Diseases (Metabolic Disease) 01/2008
1	Metabolic Bone Diseases (Osteopenia) 01/2007
1	Chronic Disease (Chronic Diseases) 07/2006
1	Mastodynia 06/2006
1	Ductal Carcinoma 05/2004
1	Neoplasm Metastasis (Metastasis) 05/2004
1	Carotid Artery Diseases 01/2003
1	Atherosclerotic Plaque (Atheroma) 01/2003

Drug/Important Bio-Agent (IBA)

15	Estrogens (Estrogen)FDA Link 01/2021 - 01/2003
13	Contraceptive Agents (Contraceptives)IBA 01/2022 - 06/2007
13	Progestins (Progestagens)IBA 04/2021 - 12/2004
9	Hormones (Hormone)IBA 01/2016 - 11/2005
6	Biological ProductsIBA 12/2021 - 01/2008
3	factor V LeidenIBA 01/2018 - 10/2003
3	Combined Oral ContraceptivesIBA 10/2015 - 04/2009
2	Protein CIBA 09/2020 - 02/2017
2	Progesterone FDA LinkGeneric 10/2017 - 11/2010
2	Prothrombin (Factor II)IBA 02/2017 - 10/2003
2	Oral ContraceptivesIBA 02/2013 - 06/2006
2	Biomarkers (Surrogate Marker)IBA 06/2007 - 06/2006
1	Follicle Stimulating Hormone (Follitropin)FDA Link 12/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	AnticoagulantsIBA 09/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	AntibodiesIBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2017
1	Protein SIBA 02/2017
1	norgestimate FDA LinkGeneric 10/2015
1	Antihypertensive Agents (Antihypertensives)IBA 04/2014
1	A-factor (Streptomyces)IBA 11/2012
1	Gonadal Steroid Hormones (Sex Hormones)IBA 06/2012
1	NorpregnanesIBA 11/2010
1	NeurotensinIBA 01/2009
1	ProlactinIBA 01/2008
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 06/2007
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2007
1	Chlormadinone Acetate (Chlormadinone)IBA 12/2004
1	Phosphotransferases (Kinase)IBA 05/2004
1	Estrogen ReceptorsIBA 05/2004
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2004
1	Death-Associated Protein KinasesIBA 05/2004
1	Proteins (Proteins, Gene)FDA Link 05/2004

Therapy/Procedure

13	Therapeutics 11/2019 - 08/2003
5	Contraception (Birth Control) 01/2022 - 12/2004
5	Hormonal Contraception 11/2019 - 12/2004
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2010 - 01/2003
2	Ovariectomy (Oophorectomy) 11/2020 - 03/2014
1	Drug Therapy (Chemotherapy) 01/2022
1	Conservative Treatment 04/2021
1	Postcoital Contraception (Emergency Contraception) 09/2019
1	Contraindications 01/2016